This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on July 16, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Oxford Nanopore Sequencing Reagents
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health intends to award a non-competitive contract to Oxford Nanopore Technologies Inc. for the procurement of Oxford Nanopore sequencing reagents under the Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, with a maximum value not exceeding $350,000. This action is justified by the unique capability of nanopore-based sequencing to generate extremely long DNA reads exceeding 100 kb, which are essential for resolving complex regions of the human genome and supporting ongoing intramural research at the NIH Intramural Sequencing Center. The reagents are required to maintain continuous support for over 50 laboratories across more than ten institutes, processing thousands of samples annually, and no alternative technology currently provides comparable performance for this specialized application. The procurement is classified under NAICS code 541713 with a size standard of $10 million and will be executed without competition based on statutory authority for single-source acquisition. Responses to this presolicitation notice must be received by July 27, 2026, at 9:00 AM Eastern Time and must include a technical proposal, cost-price proposal, period of performance, Unique Entity ID, Taxpayer Identification Number, business size certification, and active SAM registration. Interested parties may submit capability statements to demonstrate their ability to fulfill the requirement, but the government retains full discretion to determine whether to proceed without competition or initiate a competitive process. All submissions must reference solicitation number 75N98026Q00696 and be sent electronically to James Law at James.Law@nih.gov; fax responses are not accepted. The reagents are available on the GSA Schedule GS-07F-5934R, Sin #334516 through Government Scientific Source, Inc., and the contract will incorporate all applicable clauses under FAC 2026-01. The contracting office is located at 6701 Rockledge Drive, Bethesda, MD 20817.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
General Information
Document Type:
Presolicitation
Synopsis Number:
75N98026Q00696
Posted Date:
July 16, 2026
Original Response Date:
July 27, 2026
Current Response Date:
July 27, 2026
Set Aside:
N/A
NAICS Code:
541713
Contracting Office Address
National Institutes of Health (NIH), Office of the Director (OD)
Office of Logistics and Operations (OLAO)
Office of Acquisition and Logistics Management (OALM)
Hospital and Laboratory Support Division
6701 Rockledge Drive
Bethesda, MD 20817
Description
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:
Oxford Nanopore Technologies Inc.
101 Avenue of the Americas
New York 10013
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 541713 with a Size Standard $1000.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
GENERAL INFORMATION
- Title: Oxford Nanopore Sequencing Reagents
- Background Information: The NIH Intramural Sequencing Center (NISC) is a centralized research facility for performing high-throughput, large-scale DNA sequencing and sequence analysis. Nanopore-based sequencing is a new technology that is fast emerging for its unique ability to produce extremely long reads, exceeding 100 kb. This is very powerful for DNA sequence assembly in repeat regions and for determining haplotypes. NISC is working with investigators who are trying to complete unresolved regions of the human genome. For this work extremely long reads that only this technology can currently provide are required. NISC requires reagents to meet sequencing demands on this platform.
NISC directly supports >50 laboratories across >10 ICs by processing thousands of samples annually for highly specialized sequencing analysis and purchase of these reagents will continue to support these ongoing studies. Failure to purchase these reagents will compromise the ability of NISC to support intramural research. These reagents are available on GSA Schedule GS-07F-5934R, Sin # 334516 through Government Scientific Source, Inc..
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by July 27, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00696. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
